Table 1. Clinical and pathologic features of colorectal cancer patients.

Feature (N=100)	Variable	N	TFU of tumor	P	TFU of CAF	P	RTL	P
Age (years)	<65	64	1,535 (572–4,897)	0.245	2,885 (1,873–3,913)	0.046	0.73 (0.25–2.5)	0.815
	≥65	36	2,718 (576–7,514)		2,317 (1,309–3,223)		0.99 (0.28–1.87)
Gender	Male	45	2,082 (457–5,779)	0.967	2,600 (1,764–3,738)	0.386	0.71 (0.20–2.1)	0.406
	Female	55	1,876 (655–4,315)		2,271 (1,575–3,337)		0.92 (0.37–2.0)
Tumor location	Right colon	26	1,292 (334–5,726)	0.505	1,855 (739–2,831)	0.127	1.07 (0.31–3.20)	0.657
	Left colon	74	2,082 (616–5,486)		2,437 (1,776–3,506)		0.92 (0.25–1.96)
Differentiation	Well	54	2,189 (691–5,779)	0.260	2,437 (1767–3,542)	0.303	0.94 (0.29–2.30)	0.879
	Moderate–poor	46	1,085 (481–5,709)		2,162 (1,268–2,993)		0.92 (0.18–1.92)
T stage	T1-2	38	2,066 (698–6,235)	0.643	2,599 (1,964–3,581)	0.212	0.71 (0.25–2.53)	0.587
	T3-4	62	1,879 (523–5,450)		2,254 (1,340–3,484)		0.94 (0.29–1.96)
Lymph node metastasis	Negative	52	1,820 (669–4,715)	0.776	2,440 (1,764–3,463)	0.849	0.74 (0.26–1.97)	0.581
	Positive	48	2,198 (516–7,500)		2,395 (1,529–3,508)		0.84 (0.29–2.15)
Perineural invasion	Negative	97	1,994 (626–5,508)	0.021	2,451 (1,810–3,508)	0.001	0.89 (0.26–2.10)	0.577
	Positive	3	360 (130–499)		404 (384–506)		0.71 (0.34–0.75)
lymphovascular invasion	Negative	90	2,136 (631–5,666)	0.037	2,427 (1,776–3,451)	0.815	0.93 (0.29–2.53)	0.0662
	Positive	10	676 (130–1,989)		2,173 (1,042–4,876)		0.35 (0.13–1.07)
Distant metastases	Negative	89	2,314 (684–5,802)	0.002	2,550 (1,728–3,574)	0.208	0.98 (0.31–2.17)	0.020
	Positive	11	557 (130–956)		2,156 (1,261–2,427)		0.23 (0.08–0.89)
Dukes stage	A	29	1,943 (719–5,248)	0.023	2,550 (1,882–4,010)	0.447	0.74 (0.22–2.07)	0.072
	B	21	1,765 (703–5,125)		2,368 (1,106–3,334)		0.99 (0.32–2.68)
	C	39	2,759 (617–7,771)		2,799 (1,703–3,871)		1.08 (0.48–2.34)
	D	11	557 (130–956)		2,156 (1,261–2,427)		0.23 (0.08–0.89)

TFU, telomere fluorescent intensity units; CAF, cancer-associated fibroblast cell; RTL, relative telomere length.